- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02319681
Reminiscence, Anxiety and Early Alzheimer's Disease
This study seeks to establish the acceptability and evaluate the limited efficacy of Simple Reminiscence (SR), a home-delivered non-pharmacological intervention designed to relieve stress, improve affect, and prevent or quell disruptive or maladaptive behaviors in community-residing individuals diagnosed with early Alzheimer's disease (EAD). Unmanaged episodes of anxiety can be antecedents of maladaptive behaviors, including agitation, anger, and sometimes even violence.
SR is a dyadic strategy; both the person with EAD and the caregiver engaged the patient's memory to interrupt a current episode of anxiety.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Through the intervention, family caregivers are trained to collaborate with and guide patients to access positive memories as a way to manage or move past the anxiety that plagues individuals with EAD - often arising when confronted by common complex tasks they previously were able to perform.
During the project's first six months (phase 1), the investigators will develop a series of 4 video-vignettes illustrating dyads (including one member with EAD) managing a variety of anxiety provoking scenarios associated with EAD (e.g., trouble reconciling a checkbook) through the use of SR.
During the second phase of the project, a research assistant will administer SR at four home visits. The SR intervention has three components:
- A didactic component using the SR manual that the couple retains (15 minutes);
- Viewing one of the brief video-vignettes illustrating the application of reminiscence techniques (5 minutes; a different video-vignette will be viewed at each visit; and
- Facilitation of caregiver practice in applying the techniques, using a recent example of anxiety-linked experience of the person with EAD (10 minutes). The caregiver is encouraged to learn and practice the techniques in order to cue and coach the person with EAD in their use.
The attention control treatment, a Social Visit, is a 30-minute activity in which the person with EAD, the caregiver and the research assistant (RA) review and discuss the day's newspaper headlines. The RA will use communication techniques specifically designed to keep the conversation present focused.
Both members of the dyad will collect saliva to evaluate diurnal cortisol secretion.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30329
- Emory Alzheimer's Disease Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Live in the community
- Reside with a primary caregiver who must be willing to participate in all study activities (the primary caregiver must have a familial or marital relationship with the person with EAD of sufficient length to support reminiscence activity [i.e., an adult child, a long-term spouse or committed partner])
- Have received a diagnosis of Early Alzheimer's Disease from a primary care provider
- Achieve a score on the mini-mental state examination (MMSE) between 19 and 25
Exclusion Criteria:
- Unable to give consent
- MMSE score lower than 19 or greater than 25.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Simple Reminiscence (SR) caregiver
Subjects are caregivers for a persons with EAD and will be administered SR intervention and an attention control treatment four times
|
SR is a 30-minute psychoeducational activity administered by a trained RA at 4 home visits (week 2, week 3, week 7, and week 19).
SR has a didactic component using the SR manual that the couple retains, viewing one of the brief video-vignettes illustrating the application of reminiscence techniques (a different video-vignette will be viewed at each visit), and facilitation of caregiver practice in applying the techniques, using a recent example of anxiety-linked experience of the person with EAD.
AC is a 30-minute in which the person with EAD, the caregiver and the RA review and discuss the day's newspaper headlines.
The RA will use communication techniques specifically designed to keep the conversation present focused at 4 home visits (week 2, week 3, week 7, and week 19).
|
|
Experimental: Simple Reminiscence (SR) EAD
Subjects are persons with EAD and will be administered SR intervention and an attention control treatment four times
|
SR is a 30-minute psychoeducational activity administered by a trained RA at 4 home visits (week 2, week 3, week 7, and week 19).
SR has a didactic component using the SR manual that the couple retains, viewing one of the brief video-vignettes illustrating the application of reminiscence techniques (a different video-vignette will be viewed at each visit), and facilitation of caregiver practice in applying the techniques, using a recent example of anxiety-linked experience of the person with EAD.
AC is a 30-minute in which the person with EAD, the caregiver and the RA review and discuss the day's newspaper headlines.
The RA will use communication techniques specifically designed to keep the conversation present focused at 4 home visits (week 2, week 3, week 7, and week 19).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of SR and AC
Time Frame: Week 20
|
Taped interview with the dyad will occur asking how acceptable the format, duration, and frequency of the program
|
Week 20
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of times AC was used
Time Frame: Week 20
|
Taped interview with the dyad will occur asking how frequently AC was used
|
Week 20
|
|
Number of times SR was used
Time Frame: Week 20
|
Taped interview with the dyad will occur asking how frequently SR was used
|
Week 20
|
|
Change in Beck Depression Inventory-II (BDI-II) scale
Time Frame: Baseline, week 20
|
BDI-II is a 21-item, self-administered tool used to measure depressive symptoms.
Scores range from 0 - 63, with higher scores indicating more severe depressive symptoms.
|
Baseline, week 20
|
|
Change in State-Trait Anxiety Inventory (STAI) scale
Time Frame: Baseline, week 20
|
STAI is a 20-item tool that measures current anxiety symptoms with scores that range from 20 to 80, with higher scores indicating greater levels of anxiety.
|
Baseline, week 20
|
|
Change in Katz Instrumental Activities of Daily Living (IADL) scale
Time Frame: Baseline, week 20
|
IADL is a six-item tool assessing the degree of independence vs. dependence in basic activities of daily living, with higher scores indicating greater levels of daily functioning.
|
Baseline, week 20
|
|
Change in Well-Being Picture Scale (WBPS) scale
Time Frame: Baseline, week 20
|
WBPS is a 10-item non-language based pictorial scale that measures general well-being.
Individuals are asked to mark the point along each scale to indicate which image they feel most like (drawings depicting a sense of high or low well-being are arranged at opposite ends of a scale).
|
Baseline, week 20
|
|
Change in Short Psychological Well-Being Scale (SPWBS) scale
Time Frame: Baseline, week 20
|
SPWBS is a 84-item self-report, Likert-type inventory that measures well-being across six dimensions: Self-Acceptance, Positive Relations With Others, Autonomy, Environmental Mastery, Purpose in Life, and Personal Growth.
A higher score indicated a greater sense of well-being.
|
Baseline, week 20
|
|
Change in Revised Memory and Behavior Problems Checklist (RMBPC) scale
Time Frame: Baseline, week 20
|
RMBPC is a 24-item Likert-type caregiver-report measure of observable behavioral problems in dementia.
|
Baseline, week 20
|
|
Caregiver's mastery of SR intervention technique
Time Frame: Week 20
|
Simple Reminiscence Intervention Mastery Assessment (SRIMA) evaluation rubric to be used to determine the person with EAD's and their caregiver's mastery of the SR Intervention techniques.
|
Week 20
|
|
Change in levels of cortisol
Time Frame: Baseline, Week 20
|
Both members of the dyad will collect saliva to evaluate diurnal cortisol secretion by standard enzyme-linked immunoabsorbant assay ( ELISA).
|
Baseline, Week 20
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: William Puentes, PhD RN FAAN, Emory University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00075912
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease
-
University of SaskatchewanCenter of Molecular Immunology, CubaNot yet recruitingMild Alzheimer's Disease | Moderate Alzheimer's DiseaseCanada
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...CompletedDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaboratorsCompletedDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedTerminatedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedTerminatedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; Alzheimer's Association; Alzheimer...Active, not recruitingPreclinical Alzheimer's Disease | Early Preclinical Alzheimer's DiseaseUnited States
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceCompletedAlzheimer's Disease (AD) | Alzheimer's Disease (AD) Related DisordersFrance
Clinical Trials on Simple Reminiscence (SR)
-
Alexandria UniversityRecruiting
-
Universidad Nacional de RosarioCompleted
-
National Taipei University of Nursing and Health...Recruiting
-
Muş Alparslan UniversityRecruiting
-
Amasya UniversityThe Scientific and Technological Research Council of TurkeyCompleted
-
National Cheng-Kung University HospitalNational Science Council, TaiwanCompleted
-
Oregon Health and Science UniversityUniversity of California, Davis; National Center for Advancing Translational... and other collaboratorsCompletedCognitive Decline | Cognitive Impairment, MildUnited States
-
University of Southern DenmarkVIA University College; Nørrebro Erindringscenter - the Danish Centre for ReminiscenceCompletedConsequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.Denmark
-
University of ConnecticutNational Institute on Aging (NIA)Not yet recruiting
-
The Hashemite UniversityCompletedSCHIZOPHRENIA 1 (Disorder) | Schizophrenia Cognition Autobiographical Memory Cognitive Remediation | Hospitalized Adult PatientsJordan